Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Supha Pharmachem Ltd (NSE: SUPHA), ISIN INE549S01036 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUPHA last traded at ₹0.27 (+0.00%), with a 52-week range of ₹0.23 to ₹1.58 (as of 6 Nov 2026).
Shareholding as of Dec 2025: promoters 1.13%, FIIs 1.70%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 49/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.